Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Histologic Ex Vivo Validation of the [18F]SITATE Somatostatin Receptor PET Tracer

Nils F. Trautwein, Sven Mattern, Martina Hinterleitner, Gerald Reischl, Ralf Schirrmacher, Volker Steger, Silvio Nadalin, Konstantin Nikolaou, Johannes Schwenck, Stephan Singer and Christian la Fougère
Journal of Nuclear Medicine May 2025, jnumed.125.269619; DOI: https://doi.org/10.2967/jnumed.125.269619
Nils F. Trautwein
1Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany;
2ENETS Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sven Mattern
3Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Hinterleitner
2ENETS Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany;
4Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany;
5DFG Cluster of Excellence 2180 “Image-Guided and Functional Instructed Tumor Therapy,” University of Tuebingen, Tuebingen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerald Reischl
5DFG Cluster of Excellence 2180 “Image-Guided and Functional Instructed Tumor Therapy,” University of Tuebingen, Tuebingen, Germany;
6Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard-Karls University Tuebingen, Tuebingen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralf Schirrmacher
7Department of Oncology, Division of Oncological Imaging, University of Alberta, Edmonton, Alberta, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Volker Steger
8Department of Thoracic and Cardiovascular Surgery, German Cardiac Competence Center, University Hospital Tuebingen, Tuebingen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvio Nadalin
2ENETS Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany;
9Department of General, Visceral, and Transplant Surgery, University Hospital Tuebingen, Tuebingen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantin Nikolaou
5DFG Cluster of Excellence 2180 “Image-Guided and Functional Instructed Tumor Therapy,” University of Tuebingen, Tuebingen, Germany;
10Department of Diagnostic and Interventional Radiology, University Hospital Tuebingen, Tuebingen, Germany; and
11German Cancer Consortium, German Cancer Research Center, Partner Site Tuebingen, Tuebingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Schwenck
1Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany;
5DFG Cluster of Excellence 2180 “Image-Guided and Functional Instructed Tumor Therapy,” University of Tuebingen, Tuebingen, Germany;
6Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard-Karls University Tuebingen, Tuebingen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan Singer
2ENETS Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany;
3Department of Pathology, University Hospital Tuebingen, Tuebingen, Germany;
5DFG Cluster of Excellence 2180 “Image-Guided and Functional Instructed Tumor Therapy,” University of Tuebingen, Tuebingen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian la Fougère
1Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany;
2ENETS Center of Excellence, University Hospital Tuebingen, Tuebingen, Germany;
5DFG Cluster of Excellence 2180 “Image-Guided and Functional Instructed Tumor Therapy,” University of Tuebingen, Tuebingen, Germany;
11German Cancer Consortium, German Cancer Research Center, Partner Site Tuebingen, Tuebingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Login to the site using your SNMMI member credentials

Individuals

Non-Member Login

Login as an individual user

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Histologic Ex Vivo Validation of the [18F]SITATE Somatostatin Receptor PET Tracer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Histologic Ex Vivo Validation of the [18F]SITATE Somatostatin Receptor PET Tracer
Nils F. Trautwein, Sven Mattern, Martina Hinterleitner, Gerald Reischl, Ralf Schirrmacher, Volker Steger, Silvio Nadalin, Konstantin Nikolaou, Johannes Schwenck, Stephan Singer, Christian la Fougère
Journal of Nuclear Medicine May 2025, jnumed.125.269619; DOI: 10.2967/jnumed.125.269619

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Histologic Ex Vivo Validation of the [18F]SITATE Somatostatin Receptor PET Tracer
Nils F. Trautwein, Sven Mattern, Martina Hinterleitner, Gerald Reischl, Ralf Schirrmacher, Volker Steger, Silvio Nadalin, Konstantin Nikolaou, Johannes Schwenck, Stephan Singer, Christian la Fougère
Journal of Nuclear Medicine May 2025, jnumed.125.269619; DOI: 10.2967/jnumed.125.269619
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

Keywords

  • oncology
  • PET
  • radiotracer tissue kinetics
  • neuroendocrine neoplasms
  • SSTR PET
  • [18F]SITATE
SNMMI

© 2025 SNMMI

Powered by HighWire